Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation (Q40983879)

25 September 2017

title

Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation (English)

1 reference

25 September 2017

M Renoud-Grappin

1

1 reference

25 September 2017

C Fossey

2

1 reference

25 September 2017

G Fontaine

3

1 reference

25 September 2017

D Ladurée

4

1 reference

25 September 2017

A M Aubertin

5

1 reference

25 September 2017

A Kirn

6

1 reference

25 September 2017

publication date

1 May 1998

1 reference

Antiviral Chemistry & Chemotherapy

25 September 2017

published in

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

205-223

1 reference

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcri

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

HIV inhibitors targeted at the reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

HIV resistance to reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Syntheses of potential antimetabolites. XX. Syntheses of 5-carbomethoxymethyl- and 5-methylaminomethyl-2-thiouridine (the "first letters" of some anticodons) and closely related nucleosides from uridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Molecular targets for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2', 5'-bis-O-(tert-butyldimethylsilyl)-.beta.-D-xylo- and -ribofuranose]-3'-spiro-5''-[4''-amino-1'', 2''-oxathiole 2''

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

Synthesis of Uridylyl (3′-5′) Uridine Derivatives Containing 5-(Methylamino-Methyl) Uridine as A Modified Nucleoside Found fromE. COLIMinor tRNAArg

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900302

10.1177/095632029800900302

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference